# L-Citrulline / Citrulline Malate - Clinical Longevity Review & Consensus Audit

> **Consensus Verdict**: L-Citrulline is a neutral non-proteinogenic amino acid that bypasses hepatic first-pass arginase extraction, elevating systemic plasma L-arginine and endothelial nitric oxide synthase (eNOS) flux substantially more effectively than direct L-arginine supplementation. Double-blind placebo-controlled human trials demonstrate that oral L-citrulline reduces systemic arterial stiffness (baPWV -0.7 m/s) and central aortic blood pressure (-6 to -9 mmHg), yields a 52.9% increase in anaerobic bench press repetitions to failure, reduces delayed onset muscle soreness (DOMS) by 40% via enhanced urea cycle ammonia buffering, and restores normal erectile hardness in 50% of men with mild arteriogenic dysfunction.

## 1. Executive Summary & Scores
- **Longevity Evidence Score**: **92/100**
- **Evidence Quality Tier**: **silver**
- **Human Clinical Evidence Strength**: 94/100
- **Primary Longevity Classification**: supplements
- **Safety Margin Score**: 96/100 (Higher is safer)
- **Time Burden**: ~1 minutes/day
- **Estimated Monthly Cost**: inexpensive
- **Adherence Friction**: 1/10 (Lower is easier to sustain)

---

## 2. Biological Mechanisms of Action
Converts to L-arginine in the kidneys, driving the endothelial nitric oxide synthase (eNOS) pathway to produce nitric oxide (NO) for vasodilation.

---

## 3. Canonical Longevity Vector Impacts (The 8 Longevity Pillars)
- **Heart Health & Endothelial Function**: **94/100** [Rank #6 of 133 in Heart] - Effect: Very High (-0.7 m/s Pulse Wave Velocity, -6 to -9 mmHg Aortic Blood Pressure in Double-Blind RCT)
    - Mechanism: Bypasses hepatic arginase first-pass clearance and is converted in the kidneys into L-arginine, dramatically increasing plasma arginine and endothelial nitric oxide synthase (eNOS) flux, relaxing vascular smooth muscle.
- **Brain Longevity & Neuroprotection**: **75/100** [Rank #56 of 141 in Brain] - Effect: Moderate (Enhances cerebral microvascular perfusion and neurovascular coupling)
    - Mechanism: Expands cerebral microcirculatory perfusion and oxygen delivery to metabolically active cortical regions.
- **Metabolic Flexibility & Glycemic Control**: **70/100** [Rank #60 of 129 in Metabolic] - Effect: Moderate (Enhanced muscle microvascular recruitment and amino acid delivery)
    - Mechanism: Augments postprandial microvascular recruitment in skeletal muscle, promoting nutrient and anabolic substrate disposal.
- **Cancer Defense & DNA Repair**: **50/100** [Rank #44 of 120 in Cancer Defense] - Effect: Mild (Macrophage-mediated nitric oxide cytotoxicity homeostasis)
    - Mechanism: Supports physiological macrophage tumoricidal nitric oxide generation without excessive nitrosative stress.
- **Endocrine & Anabolic Balance**: **74/100** [Rank #12 of 120 in Endocrine] - Effect: Moderate-High (+50% Complete Erection Hardness Recovery in Men with Mild ED)
    - Mechanism: Drives endothelial nitric oxide-cyclic GMP relaxation of cavernous smooth muscle, restoring microvascular arterial inflow with zero side effects.
- **Chronic Inflammation Reduction**: **76/100** [Rank #42 of 126 in Inflammation] - Effect: Moderate-High (-40% Delayed Onset Muscle Soreness [DOMS] at 24 & 48 Hours, +52.9% Reps to Failure)
    - Mechanism: Enhances hepatic urea cycle buffering of ammonia and metabolic byproducts during intense exertion, attenuating exercise-induced muscle damage and soreness.
- **Bone Density & Connective Matrix**: **45/100** [Rank #73 of 142 in Bone Matrix] - Effect: Mild (Nitric oxide mildly regulates osteoclast resorption without direct mineralization)
    - Mechanism: Endothelial nitric oxide provides mild tonic inhibition of osteoclast-mediated bone resorption.
- **Cellular Longevity & Autophagy**: **88/100** [Rank #35 of 131 in Cellular] - Effect: High (+7.2% Total Muscular Work Output, Faster VO2 Uptake Kinetics in Clinical Trials)
    - Mechanism: Accelerates oxygen delivery kinetics and mitochondrial phosphocreatine resynthesis, improving energetic efficiency and cellular resilience against metabolic exhaustion.

---

## 4. Practical Protocol & Administration Guidelines
- **Standard Clinical Dosage**: 3-6g
- **Recommended Timing**: 30-60m Pre-workout
- **Administration Type**: supplement
- **Recommended Biomarkers to Monitor**: strength, endurance, soreness, libido, bone_density, heart_health

---

## 5. Safety, Contraindications & Drug Interactions
- **Contraindications**: Concurrent administration with prescription PDE-5 inhibitors (Sildenafil, Tadalafil) without physician oversight (risk of potentiated hypotension), Severe hypotension (resting systolic BP <90 mmHg), Known rare inborn errors of the urea cycle (citrullinemia)
- **Safety Profile**: low_risk - Extremely high gastrointestinal tolerability compared to L-arginine; zero diarrhea at standard 3-6g doses; Mild stomach fullness if taken in concentrated bolus without adequate water

---

## 6. Peer-Reviewed Human Clinical Trials & Key PMIDs
1. **Oral L-citrulline supplementation improves erection hardness in men with mild erectile dysfunction** [PMID: 21195829]
   - Link: https://pubmed.ncbi.nlm.nih.gov/21195829/
2. **Post-Exercise DOMS Reduction** [PMID: 20386132]
   - Link: https://pubmed.ncbi.nlm.nih.gov/20386132/
3. **Effects of L-citrulline oral supplementation on arterial stiffness and blood pressure in humans** [PMID: 20689506]
   - Link: https://pubmed.ncbi.nlm.nih.gov/20689506/
4. **l-Citrulline supplementation improves O2 uptake kinetics and high-intensity exercise performance in humans** [PMID: 26023227]
   - Link: https://pubmed.ncbi.nlm.nih.gov/26023227/

---

## 7. Canonical Citation & Web Verification
- **Official Web Review**: [L-Citrulline / Citrulline Malate on LongevityReviews](https://longevityreviews.org/modalities/l-citrulline)
- **Last Evidence Calibration**: 2026-09-09
- **Review Policy**: 0% sponsored placements, independent peer-reviewed consensus.